E-LIB Suche - Ergebnisse für: Campbell, Matthew T.

1

MORPHOLOGICAL PROGRESSION IN RELAPSING PATIENTS WITH SMALL ..:

Moussa, Mohammad Jad ; Radtke, Arlene O. Siefker ; Shah, Amishi Y....
Urologic Oncology: Seminars and Original Investigations. 42 (2024) - p. S30 , 2024

Link: https://doi.org/10.1016/..

2

Bone mimetic environments support engineering, propagation,..:

Paindelli, Claudia ; Parietti, Vanessa ; Barrios, Sergio...
Acta Biomaterialia. 178 (2024) - p. 83-92 , 2024

Link: https://doi.org/10.1016/..

3

Clinical outcomes of image-guided therapies in patients wit..:

Chahla, Brenda ; Pal, Koustav ; Balderrama-Brondani, Vania...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

4

Cabozantinib in patients with unresectable and progressive ..:

Jimenez, Camilo ; Habra, Mouhammed Amir ; Campbell, Matthew T...
The Lancet Oncology. 25 (2024) 5 - p. 658-667 , 2024

Link: https://doi.org/10.1016/..

5

Efficacy, Safety, and Tolerability of Tivozanib in Heavily ..:

Johns, Andrew C ; Campbell, Matthew T ; Gao, Mamie...
The Oncologist. 29 (2024) 7 - p. 589-595 , 2024

Link: https://doi.org/10.1093/..

6

Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable..:

Jackson, Jamaal C. ; Sanchez, Darren ; Johns, Andrew C....
Journal of Clinical Medicine. 13 (2024) 12 - p. 3436 , 2024

Link: https://doi.org/10.3390/..

7

Venous thromboembolism in adrenocortical carcinoma: a retro..:

Laganà, Marta ; Balderrama-Brondani, Vania ; Herrera, Kelsey Ruth...
The Oncologist. 29 (2024) 7 - p. 575-580 , 2024

Link: https://doi.org/10.1093/..

8

Durable Objective Response to Lurbinectedin in Small Cell B..:

Moussa, Mohammad Jad ; Khandelwal, Jaanki ; Wilson, Nathaniel R....
Current Oncology. 31 (2024) 6 - p. 3342-3349 , 2024

Link: https://doi.org/10.3390/..

9

Cabozantinib monotherapy for advanced adrenocortical carcin..:

Campbell, Matthew T ; Balderrama-Brondani, Vania ; Jimenez, Camilo...
The Lancet Oncology. 25 (2024) 5 - p. 649-657 , 2024

Link: https://doi.org/10.1016/..

10

Author Correction: Distinct molecular and immune hallmarks ..:

Kim, Sang T. ; Chu, Yanshuo ; Misoi, Mercy...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

11

Cabozantinib in the Routine Management of Renal Cell Carcin..:

Gross-Goupil, Marine ; Bodnar, Lubomir ; Campbell, Matthew T....
Clinical Genitourinary Cancer. 22 (2024) 1 - p. 84-97 , 2024

Link: https://doi.org/10.1016/..

12

Revisiting Treatment of Metastatic Urothelial Cancer: Where..:

Moussa, Mohammad Jad ; Campbell, Matthew T. ; Alhalabi, Omar
Biomedicines. 12 (2024) 3 - p. 519 , 2024

Link: https://doi.org/10.3390/..

13

Treatment Outcomes in Patients With Metastatic Renal Cell C..:

Hahn, Andrew W ; Surasi, Devaki Shilpa ; Viscuse, Paul V...
The Oncologist. 29 (2023) 5 - p. 392-399 , 2023

Link: https://doi.org/10.1093/..

14

Tu1734 RANDOMIZED CLINICAL TRIAL OF INFLIXIMAB VERSUS VEDOL..:

Wang, Yinghong ; Varatharajalu, Krishnavathana ; Shatila, Malek...
Gastroenterology. 164 (2023) 6 - p. S-1101 , 2023

Link: https://doi.org/10.1016/..

15

Special Issue Editorial: Emerging Therapies in Renal Cell C..:

Campbell, Matthew T. ; Zhang, Tian
Cancers. 15 (2023) 21 - p. 5262 , 2023

Link: https://doi.org/10.3390/..